Base on a new study, a novel pancreatic cancer treatment using activate of immune system shows a good progress in some patients. This novel approach to treat the pancreatic cancer activates the immune system works in some patients. Robert H. Vonderheide, MD, DPhil, an associate professor of medicine in the division of hematology/oncology and the [...]

Recently, Dana-Farber Cancer Institute at Boston is doing a small clinical trial involving volunteers with advanced pancreatic cancer. The study observed the ability of a commonly used anti-malarial drug, hydroxychloroquine, to slow down the growth of the aggressive malignancy. The results of the study will be published in the April issue of Genes & Development [...]

The treatment of pancreatic cancer is depends on the condition of the cancer that can be divided into the following 3 categories. First, it called as localized when the cancer is totally confirmed within the pancreas organ. Second, it called as locally advance when the cancer has spread or extended from the pancreas to nearby [...]